Poseida Therapeutics, Inc. (PSTX) SEC filings
PSTX SEC filings moved a median of +1.62% by the close. PSTX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the PSTX overview →
32 measured PSTX SEC filing events.
Where these PSTX SEC filings landedvs 27 measured PSTX SEC filing reactions
| Middle 50% of PSTX SEC filing reactions | +0.25% to +4.93% |
|---|---|
| Median reaction (to close) | +1.62% |
| Measured reactions | 27 |
Point-in-time · zero look-ahead
Half of the 27 PSTX SEC filing events with a measured close landed between +0.25% and +4.93%; 74% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 15-12G Poseida Therapeutics, | SEC filing · Form 15-12G | — | — | |
| Form EFFECT Poseida Therapeutics, | SEC filing · Form EFFECT | — | — | |
| Form 8-K Poseida Therapeutics, For: Jan 08 | SEC filing · Form 8-K | — | — | |
| Form POS AM Poseida Therapeutics, | SEC filing · Form POS | — | — | |
| Form S-8 POS Poseida Therapeutics, | SEC filing · Form S-8 | — | — | |
| Form 8-K Poseida Therapeutics, For: Nov 25 | SEC filing · Form 8-K | +0.22% | +1.19% | |
| Form 8-K Poseida Therapeutics, For: Nov 14 | SEC filing · Form 8-K | -0.60% | -3.60% | |
| Form 10-Q Poseida Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +7.08% | -5.23% | |
| Form 8-K Poseida Therapeutics, For: Nov 07 | SEC filing · Form 8-K | +7.08% | -5.23% | |
| Form 8-K Poseida Therapeutics, For: Sep 27 | SEC filing · Form 8-K | +2.45% | +10.00% | |
| Form EFFECT Poseida Therapeutics, | SEC filing · Form EFFECT | -1.03% | +0.00% | |
| Form 10-Q Poseida Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.33% | +1.62% | |
| Form 8-K Poseida Therapeutics, For: Aug 05 | SEC filing · Form 8-K | +0.33% | +1.62% | |
| Form S-3 Poseida Therapeutics, | SEC filing · Form S-3 | +0.33% | +1.62% | |
| Form 8-K Poseida Therapeutics, For: Jun 17 | SEC filing · Form 8-K | -1.14% | +0.76% | |
| Form 10-Q Poseida Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +7.50% | +15.33% | |
| Form 8-K Poseida Therapeutics, For: May 14 | SEC filing · Form 8-K | +7.50% | +15.33% | |
| Form EFFECT Poseida Therapeutics, | SEC filing · Form EFFECT | +1.04% | -2.08% | |
| Form 8-K Poseida Therapeutics, For: Apr 30 | SEC filing · Form 8-K | +1.11% | +2.97% | |
| Form ARS Poseida Therapeutics, For: Dec 31 | SEC filing · Form ARS | +2.46% | +4.93% | |
| Form DEF 14A Poseida Therapeutics, For: Jun 17 | SEC filing · Form DEF | +2.46% | +4.93% | |
| Form DEFA14A Poseida Therapeutics, | SEC filing · Form DEFA14A | +2.46% | +4.93% | |
| Form 8-K Poseida Therapeutics, For: Apr 17 | SEC filing · Form 8-K | -0.74% | +0.49% | |
| Form 8-K Poseida Therapeutics, For: Apr 08 | SEC filing · Form 8-K | -0.84% | +0.67% | |
| Form S-3 Poseida Therapeutics, | SEC filing · Form S-3 | -0.84% | +0.67% | |
| Form 10-K Poseida Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -10.25% | +14.01% | |
| Form 8-K Poseida Therapeutics, For: Mar 05 | SEC filing · Form 8-K | -10.25% | +14.01% | |
| Form S-8 Poseida Therapeutics, | SEC filing · Form S-8 | +4.14% | +6.51% | |
| Form 8-K Poseida Therapeutics, For: Dec 31 | SEC filing · Form 8-K | -2.94% | -0.94% | |
| Form 8-K Poseida Therapeutics, For: Dec 10 | SEC filing · Form 8-K | -1.72% | -25.97% | |
| Form 10-Q Poseida Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.94% | +2.34% | |
| Form 8-K Poseida Therapeutics, For: Nov 09 | SEC filing · Form 8-K | +0.94% | +2.34% |
Keep exploring
More PSTX: earnings → · analyst actions → · PSTX overview →